RAGE: a novel cellular receptor for advanced glycation end products.
about
Dietary advanced glycation end products and their role in health and diseaseAdvanced Glycation End Product Recognition by the Receptor for AGEsAlbumin-derived advanced glycation end-products trigger the disruption of the vascular endothelial cadherin complex in cultured human and murine endothelial cellsRole of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cellsTIRAP, an adaptor protein for TLR2/4, transduces a signal from RAGE phosphorylated upon ligand bindingPeriodontitis and risk of diabetes mellitus.Early glycation products produce pentosidine cross-links on native proteins. novel mechanism of pentosidine formation and propagation of glycation.Altered retinoic acid metabolism in diabetic mouse kidney identified by O isotopic labeling and 2D mass spectrometry.Plasma levels of the pro-inflammatory protein S100A12 (EN-RAGE) are associated with muscle and fat mass in hemodialysis patients: a cross-sectional study.The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation.Lack of the receptor for advanced glycation end-products attenuates E. coli pneumonia in miceGenetic modifiers of atherosclerosis in miceRAGE expression in human T cells: a link between environmental factors and adaptive immune responses.Reaction of carnosine with aged proteins: another protective process?Renal liver-type fatty acid binding protein (L-FABP) attenuates acute kidney injury in aristolochic acid nephrotoxicity.Evidence that serum levels of the soluble receptor for advanced glycation end products are inversely associated with pancreatic cancer risk: a prospective study.Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic childrenDiabetes and periodontitis.Advanced glycation endproducts and osteoarthritis.Receptor for advanced glycation end products (RAGE) prevents endothelial cell membrane resealing and regulates F-actin remodeling in a beta-catenin-dependent mannerPrenatal dietary load of Maillard reaction products combined with postnatal Coca-Cola drinking affects metabolic status of female Wistar rats.Activation and resolution of periodontal inflammation and its systemic impact.The influence of type 2 diabetes mellitus on salivary matrix metalloproteinase-8 levels and periodontal parameters: A study in an Indian population.Characteristics of inflammation common to both diabetes and periodontitis: are predictive diagnosis and targeted preventive measures possible?From benefit to damage. Glutamate and advanced glycation end products in Alzheimer brain.Genetic analysis of advanced glycation end products in the DHS MIND study.Treating chronic periodontitis: current status, challenges, and future directions.sRAGE induces human monocyte survival and differentiationFundamental role of C1q in autoimmunity and inflammationN(epsilon)-(Carboxymethyl)lysine and Coronary Atherosclerosis-Associated Low Density Lipoprotein Abnormalities in Type 2 Diabetes: Current Status.Cellular signaling and potential new treatment targets in diabetic retinopathy.Molecular mechanisms involved in the bidirectional relationship between diabetes mellitus and periodontal disease.Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives.Role of the advanced glycation end products receptor in Crohn's disease inflammation.Increased expression of the receptor for advanced glycation end products in neurons and astrocytes in a triple transgenic mouse model of Alzheimer's disease.New thoughts on the initiation of mucositis.HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation.Oxidative stress and β-amyloid protein in Alzheimer's disease.Pathophysiology of the diabetic kidney.The emerging role of the receptor for advanced glycation end products on innate immunity.
P2860
Q26801247-3A9951AD-D19F-41FF-8BCD-91B3FBDA67BFQ27667822-AA6750D9-A43C-439A-9A36-3790987EBD9EQ28362386-79CA869F-FE67-4019-BB16-A7E37B050C62Q28570142-8C0B5432-5AE6-4225-ADFC-F9DBC9E24EF1Q28741936-AFE8852E-056D-4357-A5E1-12C25729B6ABQ30394549-248FF369-18F6-441E-B0E5-8819091993A5Q31561110-6355198F-021D-4B16-9291-4AEB16508BEAQ33608656-E1AA7614-5ECA-40CD-85DF-38A90DDDB013Q33723012-689F9086-C617-45D0-AD6E-240AF7D82112Q33853348-E1012B26-F46A-4523-A2A8-AEC79E2D8DE5Q33918403-D0687445-B52A-4A9E-84BD-699BA6DEFFBDQ34080318-BE7B81D7-26C1-488E-A65B-D8F13295C2F6Q34235391-D6524CC1-A356-4E7A-9EB7-9664D764C974Q34614510-A872C0E8-5997-460F-8B33-1E99693034A8Q34760887-269CEF94-BC82-4D14-8E27-5421D14ECEC8Q34987953-8320CEBD-6672-4FCB-A82B-0678D6EB509FQ35039955-336CF910-C9E7-49EE-88E1-99A794D91C29Q35053820-89BFA6C3-D764-499D-A8D1-090C95BE0039Q35067948-CC09F35C-61F0-4F58-805A-CFE2463EE7D2Q35266372-18B06984-77EA-4E62-A9B9-F6A533266784Q35539571-667D5E40-E3F4-49B9-B96F-81DFA509C9D0Q35932966-898615E4-27B2-4874-96AE-6D879248BE04Q36059983-DD0D2261-5FCD-413D-B11F-786DAF064824Q36117590-81418BE8-D7E2-4C23-8BE8-6C7818CA214EQ36629895-5FE6AF1B-8672-4B5A-8C2D-899010D413CBQ36785519-C1F1CC67-DE75-4F26-95D5-B77D6799366AQ36819785-50140899-226E-440A-9F2E-97979C454E31Q36900801-57597FA0-9BF9-4928-9288-8CB8C1FC3A85Q36972852-F69699D9-0E97-437C-9B70-920ADC06DA84Q37036184-1DFBBB7A-2D01-4DBC-B21E-F56B42069EEEQ37089750-48BB4FC9-D821-480A-BF10-7215DB4D10D7Q37158663-DCD22700-7007-4D23-ABF1-BE9E043F8C72Q37226580-2F77582F-CE1E-4D9A-8F15-28F329B4009FQ37378925-01F7B90F-1005-4ED6-AB3B-EF6CB2AE66C1Q37541359-D0D7F735-7DAC-4FC0-979A-C87A51748B27Q37789403-1C3F279B-B3A2-4EE3-A821-9E082BDBAB69Q37876420-7065D8E5-B5AA-4747-88CB-9AC17D6139EFQ37928994-5BF37673-0BEF-4394-B009-24398CF90A91Q38111707-EA7E9E0F-CE0C-4064-8D79-FED7831BDEDFQ38165257-B1421893-E504-4D65-BB91-3994D2B85FCF
P2860
RAGE: a novel cellular receptor for advanced glycation end products.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
RAGE: a novel cellular receptor for advanced glycation end products.
@en
type
label
RAGE: a novel cellular receptor for advanced glycation end products.
@en
prefLabel
RAGE: a novel cellular receptor for advanced glycation end products.
@en
P2093
P356
P1433
P1476
RAGE: a novel cellular receptor for advanced glycation end products.
@en
P2093
Kuwabara K
Matsumoto M
Schmidt AM
Wautier JL
P304
P356
10.2337/DIAB.45.3.S77
P407
P478
45 Suppl 3
P577
1996-07-01T00:00:00Z